Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,039 | 1,638 | 2,595 | 3,414 | 4,204 |
| Other current assets | 0 | 0 | 0 | 78 | 78 |
| TOTAL | $1,146 | $1,689 | $2,668 | $3,589 | $4,309 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 7 | 0 | 0 | 0 |
| TOTAL | $N/A | $7 | $N/A | $N/A | $N/A |
| Total Assets | $1,146 | $1,696 | $2,668 | $3,589 | $4,309 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 83 | 73 | 131 | 247 | 157 |
| Other current liabilities | 235 | 256 | 290 | 216 | 157 |
| TOTAL | $318 | $329 | $422 | $463 | $314 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $318 | $329 | $422 | $463 | $314 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,684 | 2,249 | 2,249 | 2,249 | 2,249 |
| Retained earnings | -52,068 | -51,450 | -50,464 | -49,453 | -48,482 |
| TOTAL | $827 | $1,367 | $2,246 | $3,126 | $3,995 |
| Total Liabilities And Equity | $1,146 | $1,696 | $2,668 | $3,589 | $4,309 |